0800 4 SETEK
SETEK welcomes enquiries from prospective investors. Please call our corporate advisors, Armillary Private Capital.
Vision & Mission Statement
SETEK is one of New Zealand’s leading medicinal and nutraceutical cannabis companies. Our vision is to change the world “one consistent drop at a time”.
Our mission is to become:
NZ’s most trusted producer of medical and nutraceutical cannabis products
NZ’s lowest-cost provider of 100% organic, pharmaceutical grade, cannabis medicines & CBD products
One of the world’s first net carbon-neutral indoor cannabis companies
New Zealand’s number 1 employer of choice in New Zealand’s emerging cannabis sector
Leveraging Renewable Energy
As a company, SETEK is committed to protecting and preserving the uniqueness of New Zealand’s natural and cultural environment. Implicit in our business model is the connection between the land, the plant and the people. As such, renewable energy is fundamental to our environmental strategy.
SETEK’s state-of-the-art, environmentally friendly glasshouses will be sited at our new 2.8 million sq. ft. (26 hectare) facility near Taupo, NZ.
Our Philosophy & Values
The SETEK team share a common goal of creating shared-value in everything we do. We will never lose sight of why SETEK was formed – to make a real difference in the lives of those people who will beneﬁt from our products.
Passion for Excellence
We strive for excellence in every aspect of our business. We will continuously improve and optimise to create cost-efﬁciencies and reinforce our differentiated low-cost provider strategy.
Our customers employees, investors, advisors, consultants and business partners. Everyone matters.
SETEK will maintain a strong focus on new discoveries, innovations and trends to build and maintain competitive advantage throughout our value chain.
We are on a journey to build a successful international medicinal cannabis business that will change lives for the better, whilst being gentle on our planet and its resources.
SETEK will never sell ‘bud’ for smoking. This strategy reﬂects our support for the ‘Smokefree Aotearoa New Zealand 2025’ goal.
Medicinal Cannabis in NZ
The Misuse of Drugs (Medicinal Cannabis) Amendment Act came into effect in December 2018 when the following changes came into effect:
those requiring palliation have an exception and statutory defence to the charge of possession or use of illicit cannabis
quality standards will be able to be set for medicinal cannabis products through all stages of production
Cannabidiol and any substances related to tetrahydrocannabinols that are not psychoactive are not controlled drugs
The Act is intended to improve access to quality assured medicinal cannabis based on principles of fairness, quality and safety, and compassion
Timeline for Development of the Regulations
The Minister of Health recommended the making of regulations setting quality standards for medicinal cannabis products within a year of the Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018 coming into effect.
Completion of the new regulations is expected by December 2019 with operational commencement expected early/mid-2020.